A Randomized Controlled Trial to Strengthen Existential Resiliency Among Women With Metastatic Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast Neoplasms
- Sponsor
- Cedars-Sinai Medical Center
- Enrollment
- 71
- Locations
- 1
- Primary Endpoint
- GRACE's Impact on Existential Distress (measured by survey)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The investigators group has piloted a 6-week psycho-educational program, Growing Resiliency And CouragE with Cancer™ (GRACE), that bring together a variety of strategies and experiences from an inter-professional perspective to mitigate distress among patients with an advanced cancer diagnosis. GRACE is a six-session, empirically anchored intervention emphasizing a Logotherapy (Existential Therapy) and Cognitive-Behavioral Therapy approach involving psycho-education and process-oriented experiences. The curriculum includes themes illustrated via PowerPoint slides with semi-structured delivery, video presentations, a variety of mindfulness meditation practices, and selected readings that serve to reflect and capture the theme for the week of the curriculum.
Investigators
Arash Asher, MD
Director, Cancer Survivorship & Rehabilitation
Cedars-Sinai Medical Center
Eligibility Criteria
Inclusion Criteria
- •Women with metastatic cancer with a minimum prognosis of 3 months
- •Existential or spiritual concerns
- •Reasonable medical stability as assessed by the evaluating physician
- •Commits to attending 5/6 of the GRACE classes
- •English speaking
- •Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria
- •Unstable psychiatric disorder that would detract from a group program (i.e. severe depression/anxiety not controlled medically, volatile personality disorders)
- •Cognitive impairment or cognitive linguistic impairment (i.e., aphasia) that would interfere with a group program.
Outcomes
Primary Outcomes
GRACE's Impact on Existential Distress (measured by survey)
Time Frame: Baseline to 6 weeks after baseline
Secondary Outcomes
- GRACE's Impact on anxiety (measured by survey)(Baseline to 10 weeks after baseline)
- GRACE's Impact on depression (measured by survey)(Baseline to 10 weeks after baseline)
- GRACE's Impact on hopelessness (measured by survey)(Baseline to 10 weeks after baseline)
- GRACE's Impact on loneliness (measured by survey)(Baseline to 10 weeks after baseline)
- GRACE's Impact on Existential Distress (measured by survey)(Baseline to 10 weeks after baseline)